Method for producing β-1,3-1,6-glucan
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- SOPHY INC
- Filing Date
- 2021-05-24
- Publication Date
- 2026-06-25
Smart Images

Figure 0007880054000006 
Figure 0007880054000001 
Figure 0007880054000002
Abstract
Claims
1. A method for producing a composition for inhibiting MMP-9 production, comprising β-1,3-1,6-glucan, A method characterized by comprising the step of culturing Oureobasidium pullulans strain APNN-M163 (accession number: NITE P-03377) in a glucose-containing medium to obtain β-1,3-1,6-glucan.
2. The method according to claim 1, wherein the culture medium contains a nitrate ion salt as a nitrogen source.
3. A composition for inhibiting MMP-9 production, manufactured by the method described in claim 1 or 2.
4. The MMP-9 production inhibitory composition according to claim 3, wherein the β-1,3-1,6-glucan comprises β-1,4 and β-1,2 links in addition to β-1,3 and β-1,6 links.
5. The MMP-9 production inhibitory composition according to claim 4, wherein the ratio of glucose units bound to adjacent glucose units only at the 1st and 4th positions of β-1,3-1,6-glucan to the total glucose units constituting the β-1,3-1,6-glucan is 0.04 or more and 0.08 or less.
6. The MMP-9 production inhibitory composition according to claim 4 or 5, wherein the ratio of glucose units bound to adjacent glucose units at the 1st, 2nd, 4th, and 6th positions of β-1,3-1,6-glucan to the total glucose units constituting the β-1,3-1,6-glucan is 0.04 or more and 0.08 or less.
Citation Information
Patent Citations
CULTURE PRODUCT, NEW beta-1,3-1,6 GLUCAN CONTAINED IN THE SAME AND METHOD FOR PRODUCING beta-1,3-1.6 GLUCAN USING STRAIN OF GENUS AUREOBASIDIUM
JP2004329077A
High β-glucan producing strains, β-glucan manufacturing processes and methods for screening high β-glucan producing strains
JP2020031580A
Cosmetic composition for improving skin conditions containing culture liquid of aureobasidium pullulans
KR1020150028201A